iRadimed Corporation Stock News

iRadimed Corporation IRMD reported Q4 FY21 sales of $11.87 million, up 39% Y/Y, beating the consensus of $11.63 million. Get the Inside Access Traders Are Using to Profit More and Win Bigger.

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. Johnson & Johnson (NYSE: JNJ) got the ball rolling on large-cap biopharma earnings, with

WINTER SPRINGS, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market op

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price

We've seen big tech rule the markets for a while, but now quality small-caps stocks are likely to begin stealing the headlines. The post 7 Excellent Small-Cap Stocks to Buy Before 2022 appeared first

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price

IRadimed Co. (NASDAQ:IRMD) Director James B. Hawkins sold 12,176 shares of IRadimed stock in a transaction that occurred on Monday, November 29th. The stock was sold at an average price of $46.11, for a total value of $561,435.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at []

IRadimed Corporation (NASDAQ:IRMD) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 8.37% to the previous days close as strong demand from buyers drove the stock to $43.00. Actively observing the price movement in the last trading, the stock closed the session at $39.68, falling within a range of $41.95 and Looking For A Top Momentum Stock? Why IRadimed Corporation (NASDAQ: IRMD) Is A Great Pick Read More »

IRadimed Co. (NASDAQ:IRMD) CFO Christopher K. Scott sold 26,715 shares of IRadimed stock in a transaction dated Tuesday, November 23rd. The shares were sold at an average price of $40.98, for a total transaction of $1,094,780.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. []

Related Stocks: IRMD ,

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.